Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10208068 Macrocycles as factor XIa inhibitors

Patent 10208068 was granted and assigned to Bristol-Myers Squibb on February, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Bristol-Myers Squibb

Current Assignee

Bristol-Myers Squibb

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

102080680

Patent Inventor Names

William R. Ewing0

Donald J. P. Pinto0

James R. Corte0

Wu Yang0

Date of Patent

February 19, 2019

Patent Application Number

158796190

Date Filed

January 25, 2018

Patent Citations Received

‌

US Patent 11542278 Heteroaromatic macrocyclic ether chemotherapeutic agents

‌

US Patent 11667649 Heteroaromatic macrocyclic ether chemotherapeutic agents

Patent Primary Examiner

‌

Bruck Kifle

Patent abstract

The present invention provides compounds of Formula (Ia):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10208068 Macrocycles as factor XIa inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API